Promoter genotyping and mRNA expression analysis of PTGDR gene in allergy.
Prostaglandin D2 receptors are acquiring a relevant role as potential therapeutic targets in allergy. PTGDR has been described, as a candidate gene in allergic disease however there is a lack of functional studies on this gene. Objective: the aim of this case-control study was to interrogate the potential role of PTGDR in allergy. 195 allergic patients and 112 healthy controls were included. The PTGDR promoter polymorphic positions -1289G>A, -1122T>C, -881C>T, -834C>T, -613C>T, -549T>C, -441C>T, -197T>C and -95G>T were amplified by polymerase chain reaction and sequenced. PTGDR expression levels were analyzed by q-PCR and normalized to GAPDH and TBP mRNA levels. All procedures were performed following MIQE guidelines. PTGDR expression levels were significantly higher in allergic patients than in controls (P<0.001). ROC analysis for PTGDR expression showed a sensitivity of 81.4% compared to 67% for IgE levels. In addition, differences in the genotypic distribution of -1289G>A and -1122T>C polymorphisms were found in allergic patients (P = 0.009). The results indicate that PTGDR overexpression is associated with allergy. In addition, polymorphisms -1289G>A and -1122T>C contribute to explain some of the observed expression variation. PTGDR expression could have a potential role as biomarker and pharmacogenetic factor in Allergy.